Justice Ginsburg’s ruling allowed a lawsuit filed by Connecticut pension funds against Amgen to proceed. The suit alleges that Amgen assured investors about the safety of anti-anemia drugs Aranesp and Epogen even while clinical trial were raising doubts about the safety of the drugs. The funds state that this representation…
Updated: